InvestorsHub Logo
Followers 6
Posts 137
Boards Moderated 0
Alias Born 11/27/2018

Re: studythosestocks post# 179566

Tuesday, 03/05/2019 11:02:56 PM

Tuesday, March 05, 2019 11:02:56 PM

Post# of 424759
Thanks sts, I agree w/ pretty much everything you outlined.

Odds of hitting May deadline feel like 50-50 to me as well. Having worked in regulatory submissions I can tell you this (simultaneous US/EU filings) is the norm for a lot of companies. But not knowing Amarin’s operations, it’s possible it slips to the June deadline. But I think the bottom line is this: it’s coming quickly, and probably quicker than most anticipate.

I also agree that most are not aware of these EU submission deadlines, so I thought I would share here. I’m no options expert, but I wonder what calls look like around those May and June dates. I’d expect the stock to pop on news of the EU filing. I don’t see a partner ahead of EU submission either; there is no reason for it. They can get the EU submission out now, then worry about partner later, when they’ll need them for commercialization activities. Partner has next to no impact on getting submission out the door.

On topic of priority review, I think JT described it strangely, not sure why he said what he did. They’ll assume standard review, yes; but that’s just to be responsible/conservative. They’ll request priority review at the same time they submit the sNDA, that is for sure.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News